feed,title,long_url,short_url
Benzinga,EA's Strong FY25 Start: Analysts Optimistic on Sports Titles but Cautious on Non-Sports Growth,https://benzinga.com/analyst-ratings/analyst-color/24/07/40078722/eas-strong-fy25-start-analysts-optimistic-on-sports-titles-but-cautious-on-non-spor,https://da.gd/mr7tUT
Benzinga,"Rare Disease-Focused Applied Therapeutics' Lead Candidate Govorestat Has Blockbuster Potential, Analyst Sees 140% Stock Upside",https://benzinga.com/analyst-ratings/analyst-color/24/07/40078613/rare-disease-focused-applied-therapeutics-lead-candidate-govorestat-has-blockbuster,https://da.gd/z2NYl
